News

Novel approach aids development of drug resistance testing products for HIV.

A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.

Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.

A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.

In response to further market speculation and stakeholder inquiries, Bayer is publicly disclosing the contents of its private proposal to acquire Monsanto.

BRAF, EGFR, KRAS and NRAS mutation detection assays now available in all 50 states.

ETH chemists are developing a new coating method to protect seeds from being eaten by insects. In doing so, they have drawn inspiration from the humble peach and a few of its peers.

Gain a better understanding of current interest in and future deployment of benchtop automated systems.

Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.

altona Diagnostics GmbH has announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the RealStar® Zika Virus RT-PCR Kit U.S..